Evidence map›Paper›PMID 27409079›Full record

ArticlePloS one2016

Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.

Katharine Kripke, Ping-An Chen, Andrea Vazzano, Ananthy Thambinayagam, Yogan Pillay, Dayanund Loykissoonlal, Collen Bonnecwe, Peter Barron, Eva Kiwango, Delivette Castor and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 60 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Circumcised men's perceptions, understanding and experiences of voluntary medical male circumcision in KwaZulu-Natal, South Africa.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Katharine KripkeHealth Policy Project, Avenir Health, Washington, District of Columbia, United States of America.
Ping-An ChenHealth Policy Project, Futures Group, Washington, District of Columbia, United States of America.
Andrea VazzanoHealth Policy Project, Futures Group, Washington, District of Columbia, United States of America.
Ananthy ThambinayagamU.S. Agency for International Development, Pretoria, South Africa.
Yogan PillayNational Department of Health, Pretoria, South Africa.
Dayanund LoykissoonlalNational Department of Health, Pretoria, South Africa.
Collen BonnecweNational Department of Health, Pretoria, South Africa.
Peter BarronSchool of Public health, University of the Witwatersrand, Johannesburg, South Africa.
Eva KiwangoJoint United Nations Programme on HIV/AIDS, Pretoria, South Africa.
Delivette CastorU.S. Office of the Global AIDS Coordinator, Washington, District of Columbia, United States of America.
Emmanuel NjeuhmeliU.S. Agency for International Development, Washington, District of Columbia, United States of America.ORCID http://orcid.org/0000-0001-5370-4827
Department of Health · ZAFutures Group (United States) · USAIDS United · USAvenir Health · USUnited States Agency for International Development · USUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2012, South Africa set a goal of circumcising 4.3 million men ages 15-49 by 2016. By the end of March 2014, 1.9 million men had received voluntary medical male circumcision (VMMC). In an effort to accelerate progress, South Africa undertook a modeling exercise to determine whether circumcising specific client age groups or geographic locations would be particularly impactful or cost-effective. Results will inform South Africa's efforts to develop a national strategy and operational plan for VMMC. METHODS AND

findingsThe study team populated the Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0) with HIV incidence projections from the Spectrum/AIDS Impact Module (AIM), as well as national and provincial population and HIV prevalence estimates. We derived baseline circumcision rates from the 2012 South African National HIV Prevalence, Incidence and Behaviour Survey. The model showed that circumcising men ages 20-34 offers the most immediate impact on HIV incidence and requires the fewest circumcisions per HIV infection averted. The greatest impact over a 15-year period is achieved by circumcising men ages 15-24. When the model assumes a unit cost increase with client age, men ages 15-29 emerge as the most cost-effective group. When we assume a constant cost for all ages, the most cost-effective age range is 15-34 years. Geographically, the program is cost saving in all provinces; differences in the VMMC program's cost-effectiveness across provinces were obscured by uncertainty in HIV incidence projections.

conclusionThe VMMC program's impact and cost-effectiveness vary by age-targeting strategy. A strategy focusing on men ages 15-34 will maximize program benefits. However, because clients older than 25 access VMMC services at low rates, South Africa could consider promoting demand among men ages 25-34, without denying services to those in other age groups. Uncertainty in the provincial estimates makes them insufficient to support geographic targeting.

Indexed as

AdolescentAdultAge FactorsCircumcision, MaleCost-Benefit AnalysisHIV InfectionsHumansIncidenceMaleMiddle AgedModels, StatisticalNational Health ProgramsPrevalenceSoftwareSouth AfricaVoluntary Programs

Identifiers

PMID27409079
PMCPMC4943592
OpenAlexW2463910058

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.